Cellectar Biosciences (CLRB) Total Current Liabilities (2010 - 2026)
Cellectar Biosciences (CLRB) posted Total Current Liabilities of $5.24 million for Q2 2026, down 10.7% from $5.87 million a year earlier.
Powered by 
Analysis
Cellectar Biosciences (CLRB) Total Current Liabilities (2010 - 2026) Analysis & Trends
At the end of FY2025, Cellectar Biosciences' Total Current Liabilities came in at $4.75 million, down 49.4% from FY2024.
- Annual Total Current Liabilities shows a five-year compound annual growth rate of 5.9% (FY2020 to FY2025).
- In prior years, Cellectar Biosciences' Total Current Liabilities was $9.39 million in FY2024 (-63.0%), $25.36 million in FY2023 (+120.5%), $11.5 million in FY2022 (+188.2%) and $3.99 million in FY2021 (+12.0%).
- Quarterly Total Current Liabilities has run from a low of $3.17 million in Q3 2021 to a high of $29.84 million in Q3 2023 over five years.
- The strongest year-over-year quarter for Total Current Liabilities in the past five years was Q3 2023, with growth of 319.3%; the weakest was Q1 2025, with a decline of 78.9%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 54.90 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 41.64 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 27.73 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 31.75 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -31.55 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 25.50 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 11.02 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 32.65 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 3.94 Bn |
| 10 | Cellectar Biosciences | 22.38 Mn | 22.38 Mn | - | 5.24 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.24 Mn |
| Dec 31, 2025 | 4.75 Mn |
| Sep 30, 2025 | 4.91 Mn |
| Jun 30, 2025 | 5.87 Mn |
| Mar 31, 2025 | 6.02 Mn |
| Dec 31, 2024 | 9.39 Mn |
| Sep 30, 2024 | 20.31 Mn |
| Jun 30, 2024 | 15.17 Mn |
| Mar 31, 2024 | 28.55 Mn |
| Dec 31, 2023 | 25.36 Mn |
| Sep 30, 2023 | 29.84 Mn |
| Jun 30, 2023 | 12.98 Mn |
| Mar 31, 2023 | 11.54 Mn |
| Dec 31, 2022 | 11.50 Mn |
| Sep 30, 2022 | 7.12 Mn |
| Jun 30, 2022 | 6.51 Mn |
| Mar 31, 2022 | 7.35 Mn |
| Dec 31, 2021 | 3.99 Mn |
| Sep 30, 2021 | 3.17 Mn |
| Jun 30, 2021 | 3.52 Mn |
API Access
Cellectar Biosciences Total Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=CLRB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-current-liabilities", "ticker": "CLRB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=CLRB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();